Kalamazoo, Mich. (September 22, 2014) – West Michigan Cancer Center (WMCC), a collaboration of Borgess Health and Bronson Healthcare Group, is pleased to welcome Mohammad Omaira, MD, to its hematology/medical oncology team in Kalamazoo.
Dr. Omaira earned his medical degree from the University of Damascus in the Syrian Arab Republic. He completed a residency in internal medicine and pediatrics at Hurley Medical Center in Flint, Michigan, followed by a fellowship in hematology/oncology at Michigan State University in East Lansing.
Dr. Omaira is board certified in internal medicine and board eligible in medical oncology and hematology. His clinical and research interests include hematologic malignancies—leukemias and lymphomas. Dr. Omaira is an associate of the American Society of Clinical Oncology and the American Society of Hematology.